Literature DB >> 34969362

MicroRNA-185-5p: a marker of brain-sparing in foetuses with late-onset growth restriction.

José Morales-Roselló1,2, Gabriela Loscalzo1, Eva María García-Lopez3, José Santiago Ibañez Cabellos3, José Luis García-Gimenez3,4, Antonio José Cañada Martínez5, Alfredo Perales Marín1,2.   

Abstract

To compare the expression of microRNA-185-5p (miR-185-5p) in normal foetuses and in foetuses with late-onset growth restriction (FGR) and to determine the factors influencing this expression. In a prospective study, 40 foetuses (22 of them with late-onset FGR and 18 with normal growth) were scanned with Doppler ultrasound after week 35 and followed until birth. Subsequently, blood samples from umbilical cords were collected after delivery to evaluate the expression of miR-185-5p using real-time qPCR. Finally, multivariable regression analysis was applied to determine the clinical and ultrasonographic factors influencing miR-185-5p expression in both normal and late-onset FGR foetuses. In comparison with normal foetuses, late-onset FGR foetuses expressed upregulation of miR-185-5p (2.26 ± 1.30 versus 1.27 ± 1.03 2^-ddCt, P = 0.011). Multivariable regression analysis confirmed that cerebroplacental ratio (P < 0.05) was the only determinant of this overexpression. FGR foetuses overexpress miR-185-5p in relation to brain-sparing. Future studies will be needed to investigate the role of miR-185 in the management of late-onset FGR.

Entities:  

Keywords:  MicroRNA-185-5p; foetal Doppler; foetal growth; late-onset foetal growth restriction

Mesh:

Substances:

Year:  2021        PMID: 34969362      PMCID: PMC9586576          DOI: 10.1080/15592294.2021.2023271

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.861


  59 in total

Review 1.  Endothelial dysfunction in individuals born after fetal growth restriction: cardiovascular and renal consequences and preventive approaches.

Authors:  C Yzydorczyk; J B Armengaud; A C Peyter; H Chehade; F Cachat; C Juvet; B Siddeek; S Simoncini; F Sabatier; F Dignat-George; D Mitanchez; U Simeoni
Journal:  J Dev Orig Health Dis       Date:  2017-05-02       Impact factor: 2.401

2.  Cerebroplacental ratio thresholds measured within 2 weeks before birth and risk of Cesarean section for intrapartum fetal compromise and adverse neonatal outcome.

Authors:  L N Bligh; A A Alsolai; R M Greer; S Kumar
Journal:  Ultrasound Obstet Gynecol       Date:  2018-08-05       Impact factor: 7.299

3.  Poor neonatal acid-base status in term fetuses with low cerebroplacental ratio.

Authors:  J Morales-Roselló; A Khalil; M Morlando; A Bhide; A Papageorghiou; B Thilaganathan
Journal:  Ultrasound Obstet Gynecol       Date:  2015-01-05       Impact factor: 7.299

4.  miR-185 and miR-133b deregulation is associated with overall survival and metastasis in colorectal cancer.

Authors:  Pinar Akçakaya; Susanne Ekelund; Iryna Kolosenko; Stefano Caramuta; Deniz M Ozata; Hong Xie; Ulrik Lindforss; Hans Olivecrona; Weng-Onn Lui
Journal:  Int J Oncol       Date:  2011-05-13       Impact factor: 5.650

5.  Prelabor screening for intrapartum fetal compromise in low-risk pregnancies at term: cerebroplacental ratio and placental growth factor.

Authors:  L N Bligh; A A Alsolai; R M Greer; S Kumar
Journal:  Ultrasound Obstet Gynecol       Date:  2018-12       Impact factor: 7.299

6.  Prenatal hypoxia downregulates the expression of pulmonary vascular endothelial growth factor and its receptors in fetal mice.

Authors:  Po-Nien Tsao; Shu-Chen Wei
Journal:  Neonatology       Date:  2013-03-26       Impact factor: 4.035

Review 7.  Role and therapeutic potential of VEGF in the nervous system.

Authors:  Carmen Ruiz de Almodovar; Diether Lambrechts; Massimiliano Mazzone; Peter Carmeliet
Journal:  Physiol Rev       Date:  2009-04       Impact factor: 37.312

8.  Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE).

Authors:  C Lees; N Marlow; B Arabin; C M Bilardo; C Brezinka; J B Derks; J Duvekot; T Frusca; A Diemert; E Ferrazzi; W Ganzevoort; K Hecher; P Martinelli; E Ostermayer; A T Papageorghiou; D Schlembach; K T M Schneider; B Thilaganathan; T Todros; A van Wassenaer-Leemhuis; A Valcamonico; G H A Visser; H Wolf
Journal:  Ultrasound Obstet Gynecol       Date:  2013-10       Impact factor: 7.299

9.  Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression.

Authors:  Rajesha Rupaimoole; Sherry Y Wu; Sunila Pradeep; Cristina Ivan; Chad V Pecot; Kshipra M Gharpure; Archana S Nagaraja; Guillermo N Armaiz-Pena; Michael McGuire; Behrouz Zand; Heather J Dalton; Justyna Filant; Justin Bottsford Miller; Chunhua Lu; Nouara C Sadaoui; Lingegowda S Mangala; Morgan Taylor; Twan van den Beucken; Elizabeth Koch; Cristian Rodriguez-Aguayo; Li Huang; Menashe Bar-Eli; Bradly G Wouters; Milan Radovich; Mircea Ivan; George A Calin; Wei Zhang; Gabriel Lopez-Berestein; Anil K Sood
Journal:  Nat Commun       Date:  2014-10-29       Impact factor: 14.919

Review 10.  Do miRNAs Play a Role in Fetal Growth Restriction? A Fresh Look to a Busy Corner.

Authors:  Benito Chiofalo; Antonio Simone Laganà; Alberto Vaiarelli; Valentina Lucia La Rosa; Diego Rossetti; Vittorio Palmara; Gaetano Valenti; Agnese Maria Chiara Rapisarda; Roberta Granese; Fabrizio Sapia; Onofrio Triolo; Salvatore Giovanni Vitale
Journal:  Biomed Res Int       Date:  2017-03-29       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.